Search
for
Sort by
Research 661–690 of 1000+
- Presentation and Management of Cutaneous Manifestations of COVID-19
- Comorbidities in Dermatology
- Cutaneous Manifestations of COVID-19
- Dermatologic Implications of GLP-1 Receptor Agonist Medications: A Comprehensive Review
- 104 Willingness-to-pay of patients with chronic skin diseases: A pilot study
- Adverse Cutaneous Reactions to Antipsychotics
- The Scientific Legacy of Stephen Rothman
- Obstetric Dermatology
- Cutaneous Side Effects in Non-Small Cell Lung Cancer Patients Treated with Iressa (ZD1839), an Inhibitor of Epidermal Growth Factor
- A Phase 1, Open‐Label Study of the Pharmacokinetics of Ritlecitinib in Children Aged 6–12 Years With Alopecia Areata
- Epidemiology, Treatment Patterns, and Healthcare Resource Utilization Study of Patients With Alopecia Areata in Taiwan’s National Health Insurance Research Database
- DIETARY AND PHARMACO-THERAPY IN SKIN DISEASES
- [Cutaneous effects in hormonal contraception].
- Modulating the Gut–Skin Axis in Dermatological Diseases: Mechanisms and Clinical Applications of Probiotics, Prebiotics, Synbiotics, and Postbiotics
- Long COVID and Post-Covid Conditions (PCC) in 2025
- Impact of Coronavirus in a Dermatology Outpatient Clinic: A Single-Center Retrospective Study
- Dermatological Manifestations of Pegylated Interferon alfa2a and Ribavirin Combination Therapy in Chronic HCV Patients
- Dietary Management of Skin Diseases
- Œdème angioneurotique sans anomalie de l’inhibiteur de la C1 estérase : efficacité de l’acide tranexamique
- What's New: Newly Approved Drugs for Children
- Netherton's Syndrome.
- Skin Diseases (Noncancerous)
- ETHANOLAMINE
- Pilomatricoma arising at a BCG vaccination site
- New onset of alopecia areata in a patient with SARS‐CoV‐2 infection: Possible pathogenetic correlations?
- Children with trichotillomania in COVID‐19 outbreak
- Manual of chemical peels: Superficial and medium depth
- A Screening Study on Dermatoses in Pregnancy
- Telogen effluvium, Beau lines, and acral peeling associated with COVID-19 infection
- Women's Dermatologic Diseases, Health Care Delivery, and Socioeconomic Barriers